Ensemble Capital Management’s Amgen AMGN Stock Holding History

Ensemble Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,030	Closed	-$297K	–	40
2016 Q4	$297K	Buy	+2,030	New	+$306K	0.07%	40

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ensemble Capital Management's AMGN Position: Q1 2017 in Review

Ensemble Capital Management sold out of Amgen (AMGN) in Q1 2017, closing a stake of 2,030 shares — an estimated $297K sold.

Ensemble Capital Management first reported a position in AMGN in Q4 2016 and held it in 1 quarter. The position peaked at $297K in Q4 2016. 1,601 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

Ensemble Capital Management reported no remaining Amgen position as of Q1 2017 after selling out during the quarter.
Ensemble Capital Management sold 2,030 Amgen shares in Q1 2017, an estimated $297K.
Ensemble Capital Management first reported a position in Amgen in Q4 2016 and held it in 1 quarter.
Ensemble Capital Management's Amgen position peaked at $297K in Q4 2016.
1,601 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on Ensemble Capital Management's 13F filing for Q1 2017, filed 15 May 2017.